Corteva, Inc. (CTVA) stock
Close on Nov 12, 2026Market cap $6.13BP/E 8.1Yield 7.62%
Earnings
Corteva's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Corteva's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 2, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 12, 2026before the open | $1.59B | – | -$0.08 | $0.06 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 30, 2026after the close | – | – | – | – | Release |
| Q1 FY2026ended Mar 31, 2026 | May 5, 2026after the close | $4.91B | +11.0% | $1.07 | $1.50 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 3, 2026after the close | – | – | – | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 1, 2025before the open | – | – | – | – | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 6, 2025after the close | $6.46B | +5.7% | $2.02 | $2.20 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 7, 2025after the close | $4.42B | -1.7% | $0.97 | $1.13 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 5, 2025after the close | $3.98B | +7.2% | -$0.08 | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 6, 2024after the close | – | – | – | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 31, 2024after the close | $6.11B | +1.0% | $1.51 | $1.83 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 1, 2024after the close | $4.49B | -8.0% | $0.53 | $0.89 | Release |
| Q4 FY2023ended Dec 31, 2023 | Jan 31, 2024after the close | $3.71B | -3.1% | -$0.33 | $0.15 | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 27, 2023before the open | $2.60B | -6.5% | -$0.45 | -$0.23 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 3, 2023after the close | $6.05B | -3.2% | $1.23 | $1.60 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 3, 2023after the close | $4.88B | +6.2% | $0.84 | $1.16 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 1, 2023after the close | $3.83B | +10.1% | -$0.06 | $0.16 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 3, 2022after the close | $2.78B | +17.3% | -$0.45 | -$0.12 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 4, 2022after the close | $6.25B | – | $1.37 | $1.64 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 4, 2022after the close | $4.60B | – | $0.79 | $0.97 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 2, 2022after the close | $3.48B | – | $0.21 | $0.08 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 3, 2021after the close | $2.37B | – | $0.05 | -$0.14 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 5, 2021after the close | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 4, 2021after the close | – | – | – | – | Release |
| Q4 FY2020ended Dec 31, 2020 | Feb 3, 2021after the close | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 4, 2020after the close | – | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Corteva's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Adjusted Pro Forma Operating EBITDA1non-GAAP | FY2026 | $1.10B – $1.13B | – | New | Nov 12, 2026 |
| Operating EBITDAnon-GAAP | FY2026 | $4.10B – $4.30B | $4.00B – $4.20B | Raised | Jul 30, 2026 |
| Adjusted Pro Forma Operating EPS1non-GAAP | FY2026 | $0.76 – $0.80 | – | New | Nov 12, 2026 |
| Operating EPSnon-GAAP | FY2026 | $3.60 – $3.80 | $3.45 – $3.70 | Raised | Jul 30, 2026 |
| net pre-tax restructuring chargesnon-GAAP | FY2026 | $140.00M – $150.00M | – | New | Jul 30, 2026 |
Guidance history
Every forecast Corteva put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 12, 2026 | Adjusted Pro Forma Operating EBITDA1 | FY2026 | $1.10B – $1.13B | New |
| Nov 12, 2026 | Adjusted Pro Forma Operating EPS1 | FY2026 | $0.76 – $0.80 | New |
| Jul 30, 2026 | Operating EBITDA | FY2026 | $4.10B – $4.30B | Raised |
| Jul 30, 2026 | Operating EPS | FY2026 | $3.60 – $3.80 | Raised |
| Jul 30, 2026 | net pre-tax restructuring charges | FY2026 | $140.00M – $150.00M | New |
| May 5, 2026 | Operating EBITDA | FY2026 | $4.00B – $4.20B | Reaffirmed |
| May 5, 2026 | Operating EPS | FY2026 | $3.45 – $3.70 | Reaffirmed |
| Feb 3, 2026 | operating EBITDA | FY2026 | $4.00B – $4.20B | New |
| Feb 3, 2026 | Operating EPS | FY2026 | $3.45 – $3.70 | New |
| Aug 6, 2025 | Operating EBITDA | FY2025 | $3.75B – $3.85B | Raised |
| Aug 6, 2025 | Operating EPS | FY2025 | $3.00 – $3.20 | Raised |
| Aug 6, 2025 | repurchase of shares | FY2025 | $1.00B | Raised |
| Aug 6, 2025 | net pre-tax restructuring charges | FY2025 | $150.00M – $165.00M | Lowered |
| Aug 6, 2025 | net sales | FY2025 | $17.60B – $17.80B | Raised |
| May 7, 2025 | Operating EBITDA1 | FY2025 | $3.60B – $3.80B | Reaffirmed |
| May 7, 2025 | Operating EPS1 | FY2025 | $2.70 – $2.95 | Reaffirmed |
| May 7, 2025 | net pre-tax restructuring charges | FY2025 | $150.00M – $165.00M | New |
| May 7, 2025 | net sales | FY2025 | $17.20B – $17.60B | Reaffirmed |
| Feb 5, 2025 | Operating EBITDA growth at the mid-point | FY2025 | +10% | New |
| Feb 5, 2025 | Operating EBITDA | FY2025 | $3.60B – $3.80B | Lowered |
| Feb 5, 2025 | Operating EPS growth at the mid-point | FY2025 | +10% | New |
| Feb 5, 2025 | Operating EPS | FY2025 | $2.70 – $2.95 | New |
| Feb 5, 2025 | net sales growth at the mid-point | FY2025 | +3% | New |
| Feb 5, 2025 | net sales | FY2025 | $17.20B – $17.60B | Lowered |
| Nov 6, 2024 | Operating EBITDA | FY2024 | $3.35B – $3.45B | Lowered |
| Nov 6, 2024 | operating EBITDA | FY2025 | $3.60B – $4.00B | New |
| Nov 6, 2024 | Operating EPS | FY2024 | $2.50 – $2.60 | Lowered |
| Nov 6, 2024 | Free Cash Flow | FY2024 | $1.50B – $2.00B | Reaffirmed |
| Nov 6, 2024 | Cash provided by operating activities from continuing operations | FY2024 | $2.10B – $2.60B | Reaffirmed |
| Nov 6, 2024 | shares repurchased | FY2024 | $1.00B | Lowered |
| Nov 6, 2024 | net sales | FY2024 | $17.00B – $17.20B | Lowered |
| Nov 6, 2024 | net sales | FY2025 | $17.30B – $17.70B | New |
| Jul 31, 2024 | Operating EBITDA | FY2024 | $3.40B – $3.60B | Lowered |
| Jul 31, 2024 | Operating EPS | FY2024 | $2.60 – $2.80 | Lowered |
| Jul 31, 2024 | Free Cash Flow | FY2024 | $1.50B – $2.00B | Reaffirmed |
| Jul 31, 2024 | Cash provided by operating activities – continuing operations | FY2024 | $2.10B – $2.60B | Reaffirmed |
| Jul 31, 2024 | net sales | FY2024 | $17.20B – $17.50B | Lowered |
| May 1, 2024 | Operating EBITDA | FY2024 | $3.50B – $3.70B | Reaffirmed |
| May 1, 2024 | Operating EPS | FY2024 | $2.70 – $2.90 | Reaffirmed |
| May 1, 2024 | Free Cash Flow | FY2024 | $1.50B – $2.00B | Reaffirmed |
| May 1, 2024 | Cash provided by operating activities – continuing operations | FY2024 | $2.10B – $2.60B | New |
| May 1, 2024 | net sales | FY2024 | $17.40B – $17.70B | New |
| Jan 31, 2024 | Operating EBITDA | FY2024 | $3.50B – $3.70B | New |
| Jan 31, 2024 | Operating EPS | FY2024 | $2.70 – $2.90 | New |
| Jan 31, 2024 | Free cash flow | FY2024 | $1.50B – $2.00B | New |
| Jan 31, 2024 | Cash provided by operating activities – continuing operations | FY2024 | $2.10B – $2.60B | New |
| Jan 31, 2024 | net sales | FY2024 | $17.40B – $17.70B | New |
| Oct 27, 2023 | Operating EBITDA | FY2023 | $3.25B – $3.45B | Lowered |
| Oct 27, 2023 | Operating EPS | FY2023 | $2.50 – $2.70 | Lowered |
| Oct 27, 2023 | net sales | FY2023 | $17.00B – $17.30B | Lowered |
| Aug 3, 2023 | Operating EBITDA | FY2023 | $3.50B – $3.65B | Lowered |
| Aug 3, 2023 | Operating EPS | FY2023 | $2.75 – $2.90 | Lowered |
| Aug 3, 2023 | net sales | FY2023 | $17.90B – $18.20B | New |
| May 3, 2023 | Operating EBITDA | FY2023 | $3.55B – $3.75B | Raised |
| May 3, 2023 | Operating EPS | FY2023 | $2.80 – $3.00 | Raised |
| May 3, 2023 | net sales | FY2023 | $18.60B – $18.90B | Raised |
| Feb 1, 2023 | Operating EBITDA | FY2023 | $3.40B – $3.60B | New |
| Feb 1, 2023 | Operating EPS | FY2023 | $2.70 – $2.90 | New |
| Feb 1, 2023 | net sales | FY2023 | $18.10B – $18.40B | New |
| Nov 3, 2022 | Operating EBITDA | FY2022 | $3.00B – $3.10B | Raised |
| Nov 3, 2022 | Operating EPS | FY2022 | $2.45 – $2.60 | Reaffirmed |
| Nov 3, 2022 | net sales | FY2022 | $17.20B – $17.50B | New |
| Aug 4, 2022 | Operating EBITDA | FY2022 | $2.95B – $3.10B | Raised |
| Aug 4, 2022 | Operating EPS | FY2022 | $2.45 – $2.60 | Raised |
| Aug 4, 2022 | net sales | FY2022 | $17.20B – $17.50B | Raised |
| May 4, 2022 | Operating EBITDA | FY2022 | $2.80B – $3.00B | Reaffirmed |
| May 4, 2022 | Operating EPS | FY2022 | $2.35 – $2.55 | Raised |
| May 4, 2022 | net sales | FY2022 | $16.70B – $17.00B | Reaffirmed |
| Feb 2, 2022 | Operating EBITDA | FY2022 | $2.80B – $3.00B | New |
| Feb 2, 2022 | Operating EPS | FY2022 | $2.30 – $2.50 | New |
| Feb 2, 2022 | net sales | FY2022 | $16.70B – $17.00B | New |
| Nov 3, 2021 | Operating EBITDA | FY2021 | $2.50B – $2.60B | New |
| Nov 3, 2021 | Operating EPS | FY2021 | $2.05 – $2.15 | New |
| Nov 3, 2021 | net sales | FY2021 | $15.50B – $15.70B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Corteva filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- News
- News
- News
- News
- Update
- News
- News
- Update
- Update
- Results
- Results
- Update
See a number that looks wrong?